Skip to Main Content

Pamela Kunz, MD

Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion, Medical Oncology



Dr. Kunz joins Yale from Stanford University School of Medicine where she was Director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship. Beyond her record of accomplishment in GI Oncology, Dr. Kunz is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis.

Learn more about Dr. Kunz >>

Education & Training

  • Oncology Fellow
    Stanford University (2008)
  • Chief Resident
    Stanford University (2005)
  • Internal Medicine Resident
    Stanford University (2004)
  • MD
    Dartmouth Medical School (2001)
  • BA
    Dartmouth College, Biology (1994)

Departments & Organizations